The International Innovation Grant will Fund Research on the Effectiveness of Community Screening Programs for the Early Detection of Oral…
By Dr. Luke Fletcher Willamette Valley Cancer Institute & Research Center The Zuma 7 trial is a randomized, open-label multicenter…
By Dr. Dipesh Uprety Karmanos Cancer Institute
By Dr. Radhika Kulkarni Henry Ford Cancer Institute On March 2nd, 2023, results of the Phase 2 trial, SWOG…
On March 16, 2023, the U.S. Food and Drug Administration approved dabrafenib and trametinib for pediatric patients 1 year of…
By Dr. Dipesh Uprety Karmanos Cancer Institute While immunotherapy is being used religiously for non-oncogene-addicted advanced non-small cell lung…
By Dr. Kanak Parmar Texas Tech University Perioperative systemic therapy for resectable non-small cell lung cancer Surgical resection followed…
By Dr. Tarik Hadid Wayne State University Human papillomavirus (HPV) is a small DS-DNA virus, and humans are the…
By Dr. Inas Abuali Massachusetts General Hospital There is a paucity of available treatment options for patients with advanced…
On March 4, 2023, the U.S. Food and Drug Administration approved expanded use of adjuvant abemaciclib with endocrine therapy for…